ABCELLERA BIOLG (ABCL)
(Delayed Data from NSDQ)
$4.24 USD
-0.23 (-5.15%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $4.21 -0.03 (-0.71%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
AbCellera Biologics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ABCL 4.24 -0.23(-5.15%)
Will ABCL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABCL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABCL
AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength?
ABCL: What are Zacks experts saying now?
Zacks Private Portfolio Services
ABCELLERA BIOLG (ABCL) Upgraded to Buy: Here's Why
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates
Other News for ABCL
AbCellera: Just Another Biotech Stock
Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday
AbCellera Biologics (ABCL) Receives Price Target Upgrade from KeyBanc | ABCL Stock News
AbCellera Biologics (ABCL) Rated Outperform by Leerink Partners | ABCL Stock News
AbCellera assumed with an Outperform at Leerink